TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05794100

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Description: One pack of each product (1 to 10) will be consumed on a separate occasion
Study: NCT05699343

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: InterOss Collagen (Bone xenograft) and InterOss Collagen Guide (Collagen membrane)
Description: Group will receive InterOss Collagen and InterOss Collagen Guide during surgical intervention visit.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: InterOss Collagen (Bone xenograft)
Description: Group will only receive InterOss Collagen during surgical intervention visit.
Study: NCT05575882

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Skin hydration
Description: Skin hydration outside flare-up areas on an initial dry skin (the same in each visit). Non invasive technique.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Skin hydration
Description: Skin hydration outside flare-up areas on an initial dry skin (the same in each visit). Non invasive technique.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Barrier function measurement
Description: TEWL measurement outside flare-up areas on an initial dry skin (the same in each visit). Non invasive technique.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Barrier function measurement
Description: TEWL measurement outside flare-up areas on an initial dry skin (the same in each visit). Non invasive technique.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Potential of hydrogen measurement (pH)
Description: pH measurement outside flare-up areas on an initial dry skin (the same in each visit). Non invasive technique.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Potential of hydrogen measurement (pH)
Description: pH measurement outside flare-up areas on an initial dry skin (the same in each visit). Non invasive technique.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical evaluation of atopic dermatitis
Description: EASI score on each visit. Non invasive technique.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Clinical evaluation of atopic dermatitis
Description: EASI score on each visit. Non invasive technique.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality of life assessment
Description: Cardiff questionnaires to assess quality of life of subjects and their family members.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Quality of life assessment
Description: Cardiff questionnaires to assess quality of life of subjects and their family members.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Assessment of the effect on itching and sleep disturbances
Description: Visual analogue scale from 0 to 10

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Assessment of the effect on itching and sleep disturbances
Description: Visual analogue scale from 0 to 10

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Assessment of the tolerance of the study product or placebo
Description: By collection of Adverse Events (AEs) on daily log and electronic Case Report Form (eCRF).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Assessment of the tolerance of the study product or placebo
Description: By collection of Adverse Events (AEs) on daily log and electronic Case Report Form (eCRF).
Study: NCT03875053

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Monitoring Device
Description: Patients wear the home sleep apnea machine overnight. Patients undergoing standard of care CRT wear the home sleep apnea machine a second time 3 months after completion of CRT.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT06329076

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan
Description: Administration of losartan tablets (50 mg)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of placebo tablets
Study: NCT04902027

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
Description: All subjects will receive Mitoxantrone Hydrochloride Liposome 20 mg/m2, IV, on day 1 of each 21-day cycle (q3w).
Study: NCT06573151

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor, anti-PD-1 antibody and P-GemOx
Description: Selinexor, 40mg, qw, po; Pegaspargase, 2500U/m2, IM, d1; Gemcitabine, 1000mg/m2, i.v., d1, d8; Oxaliplatin, 130mg/m2, i.v., d1; anti-PD1 antibody, 200mg, d2, i.v. (21d cycle);
Study: NCT05924828

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study: NCT06103981

Intervention type: OTHER
Intervention: Acute Liver Injury
Description: To evaluate the impact of acute liver injury in patients with pneumonia on hospital stay and outcome.

Intervention type: OTHER
Intervention: Acute Liver Injury
Description: To evaluate the impact of acute liver injury in patients with pneumonia on hospital stay and outcome.
Study: NCT06543134

Intervention type: PROCEDURE
Intervention: surgery
Description: ENT surgery lasting more than half an hour

Intervention type: PROCEDURE
Intervention: surgery
Description: ENT surgery lasting more than half an hour

Intervention type: PROCEDURE
Intervention: sedation scale
Description: Measurement of postoperative recovery with the Richmond agitation scale and the Riker sedation scale

Intervention type: PROCEDURE
Intervention: sedation scale
Description: Measurement of postoperative recovery with the Richmond agitation scale and the Riker sedation scale
Study: NCT05016765

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active, self-directed electrical stimulation of the median nerve
Description: Electrical stimulation of the median nerve (12 Hz, pulse width 200µs), initially at the threshold needed to see movement of the right thumb with stimulation. After initial training with the device and education in the rationale for suprathreshold stimulation, participants will choose timing and intensity of stimulation based on their momentary symptom severity and their experience with the treatment since the beginning of the study. Participant can choose right or left median nerve (we will suggest their nondominant hand to minimize interference with daily activities).
Study: NCT06459076

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)
Description: Immediately after ceasing assisted ventilation, before intubation the age-appropriate nasal prongs were applied and weight-specific high flow rates delivered using the Optiflow THRIVETM system. The flow rates applied were as follows: 0-15 kg, 2 litres kg-1 min-1；15-30 kg, 35 litres min-1; 30-50 kg, 40 litres min-1; and\>50 kg, 50 litres min-1.
Study: NCT04861831

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power Centering for Seniors intervention
Description: Power Centering for Seniors is an innovative East-meets-West intervention (75-minute, twice weekly, supervised group classes over 12 weeks) that integrates Western best practice muscle strength and balance training components with Chinese Tai Chi/Qi Gong to improve mobility and quality of life in older, community-dwelling adults. Home practice is recommended (approximately 30 minutes three times per week on non-course days). The modularly designed course consists of four cycles with six themes repeated in each cycle. Course exercises increase in intensity throughout the twelve-week intervention period. Repetition of cycles and themes prepares participants for continuing their individualized version of the program after the group course intervention is complete. This should lead to long-term practice of the exercises learned in the intervention and to sustained positive effects of the training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power Centering for Seniors intervention
Description: Power Centering for Seniors is an innovative East-meets-West intervention (75-minute, twice weekly, supervised group classes over 12 weeks) that integrates Western best practice muscle strength and balance training components with Chinese Tai Chi/Qi Gong to improve mobility and quality of life in older, community-dwelling adults. Home practice is recommended (approximately 30 minutes three times per week on non-course days). The modularly designed course consists of four cycles with six themes repeated in each cycle. Course exercises increase in intensity throughout the twelve-week intervention period. Repetition of cycles and themes prepares participants for continuing their individualized version of the program after the group course intervention is complete. This should lead to long-term practice of the exercises learned in the intervention and to sustained positive effects of the training.
Study: NCT06123494

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: SHR-A1811 6.4 mg/kg IV infusion every 3 weeks on Day 1 of each 21-day cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
Description: Ramucirumab 8mg/kg，D 1,15 + Paclitaxel 80mg/m2，D1,8,15，Q4W; Paclitaxel 80mg/m2，D1,8,15，Q4W; Docetaxel 75mg/m2，D1，Q3W; Irinotecan 150mg/m2，D1，Q2W.
Study: NCT05486663

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tactile/kinesthetic Group
Description: Tactile/kinesthetic stimulation is performed in three stages. In the first stage; for tactile stimulation; The baby is placed in the prone (prone) position in the incubator. Light massage was applied in the head, shoulder, back, legs and arms of the infants. Each massage is applied 12 times for 1 minute. Massage was performed for 5 seconds. In the second stage Kinesthetic stimulation, including elbow flexion-extension movement, palm massages, flexion-extension of the knees and legs and plantar massages, was applied while the neonate was in supine position. Each kinesthetic stimulation was performed for 5 seconds. Each movement was repeated six times, with a total duration of 5 minutes. Tactile stimulation was repeated once after kinesthetic stimulation. The total duration of TKS was 15 minutes which was performed three times daily preferably between breastfeeding or bottle feeding for 14 consecutive days.
Study: NCT06038149

Intervention type: DIAGNOSTIC_TEST
Intervention: Transthoracic echocardiogram
Description: A painless ultrasound scan of the heart.

Intervention type: DIAGNOSTIC_TEST
Intervention: Transthoracic echocardiogram
Description: A painless ultrasound scan of the heart.
Study: NCT06203288

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based social and emotional learning (MBSEL) program for educators
Description: MBSEL for educators is a program designed to improve teachers' ability to deal with stress and enhance their well-being and teaching. Lessons include: (1) Introduction to the Science, (2) Brain, Attention, \& Well-being, (3) Positive Neuroscience, (4) Mindful Teaching, (5) Embracing Self-Compassion, (6) Finding Your Compass: Intentions for Mindful Living. This 2-hour program is self-paced and delivered online.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based social and emotional learning (MBSEL) program for educators
Description: MBSEL for educators is a program designed to improve teachers' ability to deal with stress and enhance their well-being and teaching. Lessons include: (1) Introduction to the Science, (2) Brain, Attention, \& Well-being, (3) Positive Neuroscience, (4) Mindful Teaching, (5) Embracing Self-Compassion, (6) Finding Your Compass: Intentions for Mindful Living. This 2-hour program is self-paced and delivered online.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based social and emotional learning (MBSEL) program for students
Description: MBSEL program for students consists of 17 lessons taught about once a week (40-50 minutes per lesson). The core mindfulness program practices (done every day for 3 minutes three times a day) consist of focusing on one's breathing and attentive listening to a single resonant sound. The lessons focus on promoting prosocial behavior (e.g., kindness, altruism), resiliency, well-being, and reducing stress in students. It also incorporates an eco-behavioral systems orientation.
Study: NCT04688437

Intervention type: RADIATION
Intervention: standard standing-sitting posteroanterior and lateral whole spine X-ray and lumbar MRI examination
Description: Routine examination
Study: NCT06033989

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: Delayed dental implant placement after application of surface treatment to enhance Osseointegration and healing .

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sandblasted, and acid-etched
Description: Delayed dental implant placement after application of surface treatment to enhance Osseointegration and healing .

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Delayed dental implant
Description: Surgical procedure of delayed dental implant in posterior maxilla after application of surface treatment to enhance Osseointegration and healing .

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Delayed dental implant
Description: Surgical procedure of delayed dental implant in posterior maxilla after application of surface treatment to enhance Osseointegration and healing .
Study: NCT05158062

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: pembrolizumab 200 mg every three weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olaparib
Description: olaparib 300 mg twice daily (BID) during maintenance period

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bevacizumab
Description: bevacizumab 15 mg/kg Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: carboplatin AUC=5 or 6 Q3W during treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: paclitaxel 175 mg/m2 Q3W during treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel
Description: docetaxel 60 \~ 70 mg/m2 Q3W during treatment period
Study: NCT05587517

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMPOWER
Description: EMPOWER is a manualized treatment delivered based in cognitive behavioral and acceptance and commitment therapies delivered by a trained mental health professional that utilizes breathing and grounding exercises, mindfulness meditation, psychoeducation, imaginal dialogue with the patient, and coping rehearsal techniques.~The total amount of time EMPOWER intervention is about 90 minutes, about 15 minutes each module. It can either be administered in one session or many sessions to accommodate the dynamic nature of ICU, and has two booster follow-up calls (roughly 45 minutes each) in the month following initial treatment.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Supportive Conversation
Description: The Supportive Conversation will match the time and attention offered through EMPOWER, so will be about 1.5-2 hours and will have two additional follow-up calls.
Study: NCT05800743

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® Ascending Stent Graft (ASG device)
Description: Endovascular aortic repair of the ascending aorta

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® Thoracic Aortic Graft Thoracic Branch Endoprosthesis (TBE Device)
Description: Endovascular aortic repair of the ascending aorta/aortic arch

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: Open surgical repair of the ascending aorta and/or the aortic arch
Study: NCT05204628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-3621
Description: XZP-3621 tablets will be administered orally at a dose of 500 mg QD until disease progression, unacceptable toxicity withdrawal of consent, or death, whichever occurred first.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Crizotinib
Description: Crizotinib capsules will be administered orally at a dose of 250 mg BID until disease progression, unacceptable toxicity withdrawal of consent, or death, whichever occurred first.
Study: NCT06298500

Intervention type: DEVICE
Intervention: hernia repair surgery
Description: In recent years, atraumatic mesh fixation with tissue adhesive has increasingly become the method of choice. It is the recommended mesh fixation method by the International Hernia Society Guidelines. In this study patients with inguinal hernia are treated by placing a prosthetic mesh in one of the layers of the abdominal wall to cover the weakness, the mesh is fixed by Histoacryl LapFix,
Study: NCT05218317

Intervention type: DIAGNOSTIC_TEST
Intervention: in-vivo Corneal Confocal Microscopy
Description: All study subjects underwent IVCM (Rostock Cornea Module, Heidelberg Retinal Tomograph III; Heidelberg Engineering, Germany). Before the examination, two drops of topical anesthetic with proparacaine hydrochloride (Alcaine 0.5%, Alcon-Couvreur, Belgium) were applied to both eyes. A carbomer-based gel (Viscotears 0.2%; Dr. Gerhard Mann, Chem.- Pharm. Fabrik, Germany) was used as the coupling agent between the cornea and the applanating cap of IVCM. For correctly positioning the central cornea, all subjects were asked to fixate a determined fixation point and controlled with the device camera. All scans were performed in approximately 5 minutes for each eye by a single experienced ophthalmologist, masked from the subject's disease status.

Intervention type: DIAGNOSTIC_TEST
Intervention: in-vivo Corneal Confocal Microscopy
Description: All study subjects underwent IVCM (Rostock Cornea Module, Heidelberg Retinal Tomograph III; Heidelberg Engineering, Germany). Before the examination, two drops of topical anesthetic with proparacaine hydrochloride (Alcaine 0.5%, Alcon-Couvreur, Belgium) were applied to both eyes. A carbomer-based gel (Viscotears 0.2%; Dr. Gerhard Mann, Chem.- Pharm. Fabrik, Germany) was used as the coupling agent between the cornea and the applanating cap of IVCM. For correctly positioning the central cornea, all subjects were asked to fixate a determined fixation point and controlled with the device camera. All scans were performed in approximately 5 minutes for each eye by a single experienced ophthalmologist, masked from the subject's disease status.

Intervention type: DIAGNOSTIC_TEST
Intervention: in-vivo Corneal Confocal Microscopy
Description: All study subjects underwent IVCM (Rostock Cornea Module, Heidelberg Retinal Tomograph III; Heidelberg Engineering, Germany). Before the examination, two drops of topical anesthetic with proparacaine hydrochloride (Alcaine 0.5%, Alcon-Couvreur, Belgium) were applied to both eyes. A carbomer-based gel (Viscotears 0.2%; Dr. Gerhard Mann, Chem.- Pharm. Fabrik, Germany) was used as the coupling agent between the cornea and the applanating cap of IVCM. For correctly positioning the central cornea, all subjects were asked to fixate a determined fixation point and controlled with the device camera. All scans were performed in approximately 5 minutes for each eye by a single experienced ophthalmologist, masked from the subject's disease status.
Study: NCT06538454

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training
Description: The exercises will be the same in both stages: squat, bench press, stiff, rowing, hip thrust and shoulder press. Futhermore, the rest interval (2 minutes) and the exercise order (alterning upper and lower limbs) also will be the same in the stages.~In the chronic experiment, the resistance training will be carried for 10 weeks with 2 weekly sessions in alternate days. The sets in both groups will be carried close to muscle failure.~The difference between groups is the intensity, who reflects the repetition zone. The 80%1RM group will be perform 8-10 repetitions per set, while the 60%1RM group will be perform 18-20 repetitions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training
Description: The exercises will be the same in both stages: squat, bench press, stiff, rowing, hip thrust and shoulder press. Futhermore, the rest interval (2 minutes) and the exercise order (alterning upper and lower limbs) also will be the same in the stages.~In the chronic experiment, the resistance training will be carried for 10 weeks with 2 weekly sessions in alternate days. The sets in both groups will be carried close to muscle failure.~The difference between groups is the intensity, who reflects the repetition zone. The 80%1RM group will be perform 8-10 repetitions per set, while the 60%1RM group will be perform 18-20 repetitions.